Saleh, A.; Thanassoulas, A.; Aliyev, E.; Swann, K.; Naija, A.; Yalcin, H.C.; Lai, F.A.; Nomikos, M.
Development of Recombinant PLC-Zeta Protein as a Therapeutic Intervention for the Clinical Treatment of Oocyte Activation Failure. Biomedicines 2024, 12, 1183.
https://doi.org/10.3390/biomedicines12061183
AMA Style
Saleh A, Thanassoulas A, Aliyev E, Swann K, Naija A, Yalcin HC, Lai FA, Nomikos M.
Development of Recombinant PLC-Zeta Protein as a Therapeutic Intervention for the Clinical Treatment of Oocyte Activation Failure. Biomedicines. 2024; 12(6):1183.
https://doi.org/10.3390/biomedicines12061183
Chicago/Turabian Style
Saleh, Alaaeldin, Angelos Thanassoulas, Elnur Aliyev, Karl Swann, Azza Naija, Huseyin C. Yalcin, F. Anthony Lai, and Michail Nomikos.
2024. "Development of Recombinant PLC-Zeta Protein as a Therapeutic Intervention for the Clinical Treatment of Oocyte Activation Failure" Biomedicines 12, no. 6: 1183.
https://doi.org/10.3390/biomedicines12061183
APA Style
Saleh, A., Thanassoulas, A., Aliyev, E., Swann, K., Naija, A., Yalcin, H. C., Lai, F. A., & Nomikos, M.
(2024). Development of Recombinant PLC-Zeta Protein as a Therapeutic Intervention for the Clinical Treatment of Oocyte Activation Failure. Biomedicines, 12(6), 1183.
https://doi.org/10.3390/biomedicines12061183
